Background: This study sought to understand the most common uses and functions of mobile phones in monitoring and managing diabetes, their potential role in a clinical setting, and the current state of research in this area. Methods: We identified peer-reviewed articles published between 2000 and 2010. Twenty-one articles were analyzed for this systematic literature review. Results: The majority of studies examined the use of mobile phones from the patient's perspective. Subjects with type 1 diabetes were enrolled exclusively in over 50% of the studies. Seventy-one percent of the studies used a study-specific application, which had supplemental features in addition to text messaging. The outcomes assessed varied considerably across studies, but some positive trends were noted, such as improved self-efficacy, hemoglobin A1c, and self-management behaviors. Conclusions: The studies evaluated showed promise in using mobile phones to help people with diabetes manage their condition effectively. However, many of these studies lacked sufficient sample sizes or intervention lengths to determine whether the results might be clinically or statistically significant. Future research should examine other key issues, such as provider perceptions, integration into a healthcare practice, and cost, which would provide important insight into the use of mobile phones for chronic disease management.
Introduction

D
iabetes is a well-documented health problem in the United States and worldwide. The Centers for Disease Control and Prevention reports that about 25.8 million people (8.3%) in the United States have been diagnosed with this disease. 1 Worldwide, approximately 220 million people have diabetes, and estimates suggest this number will grow to 366 million by 2030. 2 Past research has found that patients who use self-monitoring techniques, including monitoring food intake, physical activity, and glucose levels, have better control of their disease. 3, 4 One way that has been proposed to help individuals better manage their diabetes is through use of mobile phones, which are now widely available, offer a variety of communication methods, and are relatively inexpensive. The availability of mobile phones worldwide is growing, and at the end of 2010 the International Telecommunications Union posits that there will be an estimated 5.3 billion mobile cellular subscriptions. 5 Text messaging, also known as short message service (SMS), is a relatively low cost way to send asynchronous messages via mobile phones and is increasing in popularity. An estimated 200,000 text messages are sent every second. 5 In the United
States, among teenagers (12-17 years old) who have a mobile phone, over 54% send daily text messages, and almost half send 50 or more text messages per day. 6 Additionally, a recent report from the Pew
Research Center 7 states that 7% of mobile phone users have used their phone to search for health or medical information. This trend is higher among younger people, as 29% of 18-29 year olds have performed this type of search. The use and prevalence of mobile applications are also on the rise, as evidenced by the fact that a search for ''Diabetes'' within the iPhone Ò (Apple) App store yields 262 results as of March 2011. Because of the seemingly ubiquitous nature of mobile phones, many researchers and health providers have used mobile phones as a way to educate or help people to manage their health issues. [8] [9] [10] [11] [12] Similar to previous research that has examined the use of mobile phones for diabetes, 10 this study sought to examine the types of mobile phone-based interventions implemented among people with diabetes and the potential effect of these interventions on patient outcomes.
Methods
SEARCH STRATEGY
This study began by searching the following electronic databases: Science Citation Index Expanded, Social Sciences Index, Art & Humanities Citation Index, and ProQuest for peer-reviewed articles published between 2000 and May 2010. Search terms included various combinations of the terms ''diabetes,'' ''diabetes mellitus,'' ''mobile phone,'' ''cell phone,'' ''cellular phone,'' ''text messaging,'' ''text message,'' ''SMS,'' and ''short message service.'' References of identified articles were also searched for potential articles for inclusion. Only articles published in peer-reviewed scientific journals in English were eligible for review. The studies reviewed also had to use the mobile phone as the primary device of the intervention.
STUDY SELECTION
We identified 28 articles that met the basic criteria of our search. However, when the articles were further reviewed, seven articles were excluded, primarily because the mobile phone was not the main study intervention technology or the article was a description of a planned intervention that had not yet been implemented. Thus, in total, 21 articles were analyzed for this systematic literature review ( Table 1 ). All articles were independently reviewed and coded by the authors, and the following data were extracted: self-care/ management activities (i.e., glucose monitoring, eating/diet, physical activity), method of intervention (i.e., application, text messaging only, combination), intervention activity (i.e., diary/log, reminder, informational), outcomes measured (i.e., hemoglobin A1c [HbA1c], body mass index [BMI], self-efficacy, knowledge, satisfaction/ usefulness), and method of data transmittal. Additionally, study design and duration, type and glycemic control of diabetes, sample size, study participant (i.e., patient, physician, nurse, informal caregiver) recruitment process, phone ownership, location, costs, and reported technical issues were examined ( Table 2) . Both coders had previous coding experience and were well versed in the area of mobile health. During the process of establishing reliability, the coding scheme was refined and explicated as necessary. Once reliability was established (Krippendorff's alpha ‡ 0.8 for each coded item), any discrepancies between the two reviewers were subject to multiple reviews and then settled by consensus.
Results
STUDY DESIGNS AND SUBJECTS
The majority (95%) of studies examined the use of mobile phones from the patient perspective, while 19% took into account the healthcare providers (physicians [14%], nurses [5%]), and two studies (9.5%) included informal caregivers, such as parents of the patient. Sample sizes ranged from 6 to 100 subjects, with a mean of 38 subjects and a median number of 30. Subjects with type 1 diabetes were used exclusively in 57% of the studies, 19% had patients with type 2 diabetes only, 10% of the studies used patients with both types, and 14% of the studies did not report this information. Level of glycemic control, as measured by HbA1c, was reported in 57% of studies.
Almost half of the studies had some type of participant randomization (47.6%). Two studies utilized a crossover design in their intervention. The length of the interventions varied from 2 weeks to 1 year. The average length of intervention was 22.5 weeks, excluding two studies that did not report intervention length. Fourteen of the 21 studies described participant inclusion and exclusion criteria. Having a comorbidity was the most commonly stated exclusionary factor (23.8%), whereas the most commonly reported inclusion criterion involved participant age (62%). Treatment with insulin was required by one-third of studies. Seventy-one percent of studies explicitly stated the location of the intervention; these studies took place in the United Kingdom (n = 5), the United States (n = 4), Scandinavia (n = 3), and continental Europe (n = 2).
MOBILE PHONE TECHNOLOGIES
Over half of studies (57%) provided a mobile phone to the subjects, whereas 14% had subjects use their own phone, and 29% did not report this information. One-third of studies stated that the study paid for the mobile phone service, and two-thirds of studies did not report who paid for the service. Additionally, four studies discussed overall cost data. Technical issues, such as lost messages or limitations of coverage area, were reported in 67% of studies.
Seventy-one percent of studies used a study-specific application, which is a program that was developed for the study and has more functionalities or features than simple text messaging. The type of function (i.e., diary/log, reminders, information/education) used in the intervention varied, and many studies included multiple functions. Messages that reminded the participant to do an activity were used in 52% of the studies. Six studies (39%) used the messages as an opportunity to educate the participants with tips and information about diabetes. Eighty-one percent of studies reported using a diary function to record data such as blood glucose readings, carbohydrate or calorie consumption, or physical activity. The most common transmission methods of blood glucose values were Bluetooth Ò (Bluetooth SIG, Inc.) (62.5%), a physical wire to the phone (12.5%), or infrared signaling (12.5%) between the phone and the glucometer. Studies that did not develop or use a study-specific application used text messaging only. In these instances, subjects had to manually enter their information into the mobile phone and send it.
OUTCOMES REPORTED
The studies reviewed used many different outcome measures, making it difficult to do a rigorous analysis of the clinical findings. Outcomes related to self-care and management activities were reported by 43% of studies. These activities included glucose monitoring (67%), eating (44%), and exercise (44%). Sixty-two percent of studies reported HbA1c as an outcome measure, of which 85% reported improvements. However, statistically significant changes in HbA1c were reported in only three of the studies. BMI was an outcome in 24% of studies, and no significant changes were found. Selfefficacy was reported as an outcome by 24% of studies, and all found nonsignificant improvements. Knowledge about diabetes and diabetes management was reported as an outcome in 14.3% of studies, with improvements reported in two studies. Information about the costs associated with this type of intervention was reported in four studies. Of the 48% of studies that reported satisfaction as an outcome measure, 90% of them reported that the subjects were satisfied with this type of intervention.
Discussion
This review highlights the work that has been done in using mobile phones to help people with diabetes manage their disease and improve health and behavior outcomes. When one considers the ubiquity of mobile phones in modern life and their increasing use for health applications, the amount of research conducted about using them for diabetes management seems comparatively small. The studies evaluated demonstrate many positive trends, but few significant findings were reported. The small number of significant findings could be due to the small sample sizes; the average number of subjects in the studies reviewed here was 38, and just under half were randomized to a condition. Also worth noting is the fact that many of the studies did not report power calculations. Thus, overall, the generalizability of the data as they relate to other populations is continued " DIABETES MANAGEMENT VIA MOBILE PHONES continued " continued "
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limited. To move the field forward this issue should be addressed in all future studies. A limitation of this review, however, is that the assessment of outcomes reported was done at a more general level so as to allow for comparison across studies. HbA1c was commonly monitored, but other condition-specific factors assessed by the studies were not completely addressed in this review. It may be the case that the outcomes were more promising for other parameters not discussed here. Short intervention periods also may have impacted the reported outcomes. For example, the two studies 13, 14 that had a study period of at least a year were able to demonstrate a significant effect of the intervention on key outcomes. Additionally, because of the relatively short time frames of most studies, we are unable to determine the long-term impacts of mobile phone diabetes interventions, including retention, adherence, sustainability, and integration into the healthcare system. As diabetes is a condition that requires lifelong management and monitoring, longer intervention lengths may provide better insights. It is interesting that reports of provider interactions with the patients using the mobile phones were limited in these studies. It is not clear how additional data regarding a patient's diabetes were presented to either the patient's physician or nurse and how medical professionals then integrated this information into their practice. Patients' perceptions of usefulness were reported in just under half (48%) of the studies, with most (90%) reporting that the patients perceived the application positively. However, past research has demonstrated that gatekeepers to the introduction of new technologies are often the healthcare providers. 15 Therefore, it is important to understand providers' perceptions of the challenges and barriers to integrating new technologies that might help improve patient outcomes. There may be some hesitation by a healthcare provider or facility in adopting this type of technology, as questions of reimbursement, privacy, and liability may be issues. However, these issues may be addressed by the Food and Drug Administration, which is taking steps to formally approve these types of applications for use in healthcare.
Many healthcare providers and organizations are searching for cost-effective ways of providing high-quality healthcare to patients, and using mobile phones may prove to be one effective strategy. However, cost issues were only mentioned in four of the studies, 25, [30] [31] [32] and none mentioned reimbursement issues. Cost analysis greatly depends on the equipment used and the timing associated with the intervention, but it will never be truly accurate without measuring the costs when implemented in the ''real-world.'' Another real-world issue regards the provision of the mobile phones to the patients. Many of these studies provided the mobile phones to the patients, so it is unclear if they had their own phone and if the studies' technologies would have worked on them. Moreover, it is unknown if participants felt burdened when having to carry a second, unfamiliar phone, which could also lead to different patterns of usage than if they had used their own device. These issues are important for future studies to address if there are widespread implementation plans.
Overall, subjects' use and engagement in the mobile phone technologies utilized in the studies remain unclear. Some studies reported the number of text messages received and sent as an outcome measure, but it is impossible to gauge the actual level of patient engagement by this metric alone. Some studies only had a fraction of the participants respond to additional surveys that measured such outcomes. Additionally, in the studies that assessed the quantity and frequency of the messages, most report that a few highly active users sent the majority of the messages. Further inquiry is therefore needed to examine the characteristics of these highly active individuals and to work toward determining methods of encouraging other users to become more active. More engaged patients might demonstrate higher self-efficacy in managing their illnesses on a daily basis through use of mobile phones. In the studies reviewed, only a quarter (24%) measured self-efficacy, 13, [16] [17] [18] [19] with all reporting improvements. These improvements may lead to behavior change and better outcomes over time, but this is unlikely if the subjects do not continue using the technology or are not engaged in the activity. Future research on the use of mobile phones for improving access and quality of healthcare is seemingly endless, as many mobile applications for health are being developed, and mobile phones continue to become more prevalent. However, many of these potential applications may be outside of the purview of an individual's healthcare team or insurance company; thus access to or awareness of quality or formally approved technologies could be limited. Future studies should examine healthcare providers' acceptance and intention to work mobile phone applications into their practices as well as the impact that these applications might have on patient-provider interaction. Furthermore, research could explore if there is a difference in outcomes between an individual independently deciding to use an application versus having an application recommended by his or her healthcare provider. It is also important to determine the characteristics of patients who would actually use the mobile phones and consequently benefit the most from their use in order to define appropriate referral strategies. Again, future study designs and implementation will need to address the long-term sustainability and outcomes for these types of applications. These types of research inquiries will help to inform the efficient and effective use of mobile phones in managing chronic diseases.
This systematic review has examined studies that used mobile phones to help people manage their diabetes. However, many of the studies evaluated did not use rigorous study designs, and few statistically significant results in patient outcomes were found. Nevertheless, there is promise in that many of the outcomes had positive trends, such as for HbA1c levels, self-efficacy, and diabetes knowledge. Altogether, the studies analyzed suggest that, despite the promise of using mobile phones in this area, much more rigorous research needs to be completed if these technologies are to be proven useful in the management of diabetes. 
